{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:19:29Z","timestamp":1790831969048,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81601087"],"award-info":[{"award-number":["81601087"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471280"],"award-info":[{"award-number":["81471280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771359"],"award-info":[{"award-number":["81771359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Science and Technology Program","award":["1561000153"],"award-info":[{"award-number":["1561000153"]}]},{"name":"Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases","award":["2014B030301035"],"award-info":[{"award-number":["2014B030301035"]}]},{"name":"Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2015B050501003"],"award-info":[{"award-number":["2015B050501003"]}]},{"name":"Guangdong Provincial Engineering Center for Major Neurological Disease Treatment"},{"DOI":"10.13039\/501100002858","name":"the Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2019M663279"],"award-info":[{"award-number":["2019M663279"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016101","name":"Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016101","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Duchenne muscular dystrophy (DMD) is a devastating genetic muscular disorder with no effective treatment that is caused by the loss of dystrophin. Human induced pluripotent stem cells (hiPSCs) offer a promising unlimited resource for cell-based therapies of muscular dystrophy. However, their clinical applications are hindered by inefficient myogenic differentiation, and moreover, the engraftment of non-transgene hiPSC-derived myogenic progenitors has not been examined in the mdx mouse model of DMD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We investigated the muscle regenerative potential of myogenic progenitors derived from hiPSCs in mdx mice. The hiPSCs were transfected with enhanced green fluorescent protein (EGFP) vector and defined as EGFP hiPSCs. Myogenic differentiation was performed on EGFP hiPSCs with supplementary of basic fibroblast growth factor, forskolin, 6-bromoindirubin-3\u2032-oxime as well as horse serum. EGFP hiPSCs-derived myogenic progenitors were engrafted into mdx mice via both intramuscular and intravenous injection. The restoration of dystrophin expression, the ratio of central nuclear myofibers, and the transplanted cells-derived satellite cells were accessed after intramuscular and systemic transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We report that abundant myogenic progenitors can be generated from hiPSCs after treatment with these three small molecules, with consequent terminal differentiation giving rise to mature myotubes in vitro. Upon intramuscular or systemic transplantation into mdx mice, these myogenic progenitors engrafted and contributed to human-derived myofiber regeneration in host muscles, restored dystrophin expression, ameliorated pathological lesions, and seeded the satellite cell compartment in dystrophic muscles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates the muscle regeneration potential of myogenic progenitors derived from hiPSCs using non-transgenic induction methods. Engraftment of\u00a0hiPSC-derived myogenic progenitors could be a potential future therapeutic strategy to treat DMD in a clinical setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40659-020-00288-1","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T20:17:31Z","timestamp":1589919451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy"],"prefix":"10.1186","volume":"53","author":[{"given":"Ruojie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-528X","authenticated-orcid":false,"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"issue":"6","key":"288_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RJ, Kunkel LM. Dystrophin: the protein product of the duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328.","journal-title":"Cell"},{"issue":"9869","key":"288_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381(9869):845\u201360.","journal-title":"Lancet"},{"issue":"2","key":"288_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00109-009-0550-4","volume":"88","author":"S Bhatnagar","year":"2010","unstructured":"Bhatnagar S, Kumar A. Therapeutic targeting of signaling pathways in muscular dystrophy. J Mol Med (Berl). 2010;88(2):155\u201366.","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"288_CR4","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, Ferlini A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules. 2015;20(10):18168\u201384.","journal-title":"Molecules"},{"issue":"5","key":"288_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/mt.sj.6300145","volume":"15","author":"B Peault","year":"2007","unstructured":"Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 2007;15(5):867\u201377.","journal-title":"Mol Ther"},{"issue":"5","key":"288_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/mus.23738","volume":"47","author":"P Konieczny","year":"2013","unstructured":"Konieczny P, Swiderski K, Chamberlain JS. Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve. 2013;47(5):649\u201363.","journal-title":"Muscle Nerve"},{"issue":"5","key":"288_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrm.2016.7","volume":"17","author":"AE Almada","year":"2016","unstructured":"Almada AE, Wagers AJ. Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease. Nat Rev Mol Cell Biol. 2016;17(5):267\u201379.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"288_CR8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21(12):1455\u201363.","journal-title":"Nat Med"},{"issue":"6","key":"288_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","volume":"22","author":"NC Chang","year":"2016","unstructured":"Chang NC, Chevalier FP, Rudnicki MA. Satellite cells in muscular dystrophy\u2014lost in polarity. Trends Mol Med. 2016;22(6):479\u201396.","journal-title":"Trends Mol Med"},{"issue":"4","key":"288_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/phar.1909","volume":"37","author":"AM Reinig","year":"2017","unstructured":"Reinig AM, Mirzaei S, Berlau DJ. Advances in the treatment of duchenne muscular dystrophy: new and emerging pharmacotherapies. Pharmacotherapy. 2017;37(4):492\u20139.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"288_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015011074","volume":"25","author":"A Bajek","year":"2015","unstructured":"Bajek A, Porowinska D, Kloskowski T, Brzoska E, Ciemerych MA, Drewa T. Cell therapy in duchenne muscular dystrophy treatment: clinical trials overview. Crit Rev Eukaryot Gene Expr. 2015;25(1):1\u201311.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"6203","key":"288_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/337176a0","volume":"337","author":"TA Partridge","year":"1989","unstructured":"Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of Mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 1989;337(6203):176\u20139.","journal-title":"Nature"},{"issue":"13","key":"288_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJM199509283331303","volume":"333","author":"JR Mendell","year":"1995","unstructured":"Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, et al. Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy. N Engl J Med. 1995;333(13):832\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"288_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.jnen.0000218443.45782.81","volume":"65","author":"D Skuk","year":"2006","unstructured":"Skuk D, Goulet M, Roy B, Chapdelaine P, Bouchard JP, Roy R, et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol. 2006;65(4):371\u201386.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"288_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nmd.2006.10.003","volume":"17","author":"D Skuk","year":"2007","unstructured":"Skuk D, Goulet M, Roy B, Piette V, Cote CH, Chapdelaine P, et al. First test of a \u201chigh-density injection\u201d protocol for myogenic cell transplantation throughout large volumes of muscles in a duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord. 2007;17(1):38\u201346.","journal-title":"Neuromuscul Disord"},{"issue":"5743","key":"288_CR16","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1126\/science.1114758","volume":"309","author":"D Montarras","year":"2005","unstructured":"Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science. 2005;309(5743):2064\u20137.","journal-title":"Science"},{"issue":"1","key":"288_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mus.20560","volume":"34","author":"E Bachrach","year":"2006","unstructured":"Bachrach E, Perez AL, Choi YH, Illigens BM, Jun SJ, Del NP, et al. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve. 2006;34(1):44\u201352.","journal-title":"Muscle Nerve"},{"issue":"6","key":"288_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.stem.2007.09.016","volume":"1","author":"R Benchaouir","year":"2007","unstructured":"Benchaouir R, Meregalli M, Farini A, D\u2019Antona G, Belicchi M, Goyenvalle A, et al. Restoration of human dystrophin following transplantation of exon-skipping-engineered Dmd patient stem cells into dystrophic mice. Cell Stem Cell. 2007;1(6):646\u201357.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"288_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3727\/000000007783465064","volume":"16","author":"Y Torrente","year":"2007","unstructured":"Torrente Y, Belicchi M, Marchesi C, D\u2019Antona G, Cogiamanian F, Pisati F, et al. Autologous transplantation of muscle-derived Cd133+ stem cells in duchenne muscle patients. Cell Transplant. 2007;16(6):563\u201377.","journal-title":"Cell Transplant"},{"issue":"7119","key":"288_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature05282","volume":"444","author":"M Sampaolesi","year":"2006","unstructured":"Sampaolesi M, Blot S, D\u2019Antona G, Granger N, Tonlorenzi R, Innocenzi A, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 2006;444(7119):574\u20139.","journal-title":"Nature"},{"issue":"7","key":"288_CR21","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3727\/096368911X","volume":"21","author":"NM Vieira","year":"2012","unstructured":"Vieira NM, Valadares M, Zucconi E, Secco M, Bueno CJ, Brandalise V, et al. human adipose-derived mesenchymal stromal cells injected systemically into Grmd dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transplant. 2012;21(7):1407\u201317.","journal-title":"Cell Transplant"},{"issue":"21","key":"288_CR22","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1093\/hmg\/ddv316","volume":"24","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhu Y, Li Y, Cao J, Zhang H, Chen M, et al. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice. Hum Mol Genet. 2015;24(21):6029\u201340.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"288_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/79924","volume":"3","author":"R Galli","year":"2000","unstructured":"Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M, et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci. 2000;3(10):986\u201391.","journal-title":"Nat Neurosci"},{"issue":"4","key":"288_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2165\/11534300-000000000-00000","volume":"24","author":"M Meregalli","year":"2010","unstructured":"Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y. Stem cell therapies to treat muscular dystrophy: progress to date. Biodrugs. 2010;24(4):237\u201347.","journal-title":"Biodrugs"},{"issue":"5","key":"288_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"5858","key":"288_CR26","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"4","key":"288_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.trsl.2013.11.006","volume":"163","author":"F Rinaldi","year":"2014","unstructured":"Rinaldi F, Perlingeiro RC. Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl Res. 2014;163(4):409\u201317.","journal-title":"Transl Res"},{"key":"288_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fcell.2015.00029","volume":"3","author":"R Abujarour","year":"2015","unstructured":"Abujarour R, Valamehr B. Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges. Front Cell Dev Biol. 2015;3:29.","journal-title":"Front Cell Dev Biol"},{"key":"288_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/srep01179","volume":"3","author":"R Abujarour","year":"2013","unstructured":"Abujarour R, Valamehr B, Robinson M, Rezner B, Vranceanu F, Flynn P. Optimized surface markers for the prospective isolation of high-quality hipscs using flow cytometry selection. Sci Rep. 2013;3:1179.","journal-title":"Sci Rep"},{"issue":"5","key":"288_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"R Darabi","year":"2012","unstructured":"Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M, et al. Human Es- and Ips-derived myogenic progenitors restore dystrophin and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell. 2012;10(5):610\u20139.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"288_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s12015-011-9258-2","volume":"7","author":"R Darabi","year":"2011","unstructured":"Darabi R, Pan W, Bosnakovski D, Baik J, Kyba M, Perlingeiro RC. Functional myogenic engraftment from mouse Ips cells. Stem Cell Rev. 2011;7(4):948\u201357.","journal-title":"Stem Cell Rev"},{"issue":"2","key":"288_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5966\/sctm.2013-0095","volume":"3","author":"R Abujarour","year":"2014","unstructured":"Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D, et al. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Transl Med. 2014;3(2):149\u201360.","journal-title":"Stem Cells Transl Med"},{"key":"288_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/2157-7633.1000361","volume":"6","author":"W Feng Cai","year":"2016","unstructured":"Feng Cai W, Huang W, Wang L, Wang JP, Zhang L, Ashraf M, et al. Induced pluripotent stem cells derived muscle progenitors effectively mitigate muscular dystrophy through restoring the dystrophin distribution. J Stem Cell Res Ther. 2016;6:10.","journal-title":"J Stem Cell Res Ther"},{"issue":"6","key":"288_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.stemcr.2013.10.007","volume":"1","author":"B Borchin","year":"2013","unstructured":"Borchin B, Chen J, Barberi T. Derivation and facs-mediated purification of Pax3+\/Pax7+ skeletal muscle precursors from human pluripotent stem cells. Stem Cell Rep. 2013;1(6):620\u201331.","journal-title":"Stem Cell Rep"},{"issue":"3","key":"288_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stemcr.2014.07.001","volume":"3","author":"M Shelton","year":"2014","unstructured":"Shelton M, Metz J, Liu J, Carpenedo RL, Demers SP, Stanford WL, et al. Derivation and expansion of Pax7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rep. 2014;3(3):516\u201329.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"288_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cell.2013.10.023","volume":"155","author":"C Xu","year":"2013","unstructured":"Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A, et al. A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell. 2013;155(4):909\u201321.","journal-title":"Cell"},{"issue":"5","key":"288_CR37","first-page":"564","volume":"3","author":"T Hosoyama","year":"2014","unstructured":"Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Plos ONE. 2014;3(5):564\u201374.","journal-title":"Plos ONE"},{"issue":"9","key":"288_CR38","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nbt.3297","volume":"33","author":"J Chal","year":"2015","unstructured":"Chal J, Oginuma M, Al TZ, Gobert B, Sumara O, Hick A, et al. Differentiation of pluripotent stem cells to muscle fiber to model duchenne muscular dystrophy. Nat Biotechnol. 2015;33(9):962\u20139.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"288_CR39","first-page":"1833","volume":"11","author":"J Chal","year":"2016","unstructured":"Chal J, Al Tanoury Z, Hestin M, Gobert B, Aivio S, Hick A, et al. Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro. Nat Biotechnol. 2016;11(10):1833\u201350.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"288_CR40","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.stemcr.2017.02.020","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Cao J, Chen M, Li J, Sun Y, Zhang Y, et al. Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of Tsc2 neurological abnormalities. Stem Cell Rep. 2017;8(4):883\u201393.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"288_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1634\/stemcells.2006-0694","volume":"25","author":"J Chan","year":"2007","unstructured":"Chan J, Waddington SN, O\u2019Donoghue K, Kurata H, Guillot PV, Gotherstrom C, et al. Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic Mdx mouse. Stem Cells. 2007;25(4):875\u201384.","journal-title":"Stem Cells"},{"issue":"33","key":"288_CR42","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.1073\/pnas.0502507102","volume":"102","author":"G Wernig","year":"2005","unstructured":"Wernig G, Janzen V, Schafer R, Zweyer M, Knauf U, Hoegemeier O, et al. The vast majority of bone-marrow-derived cells integrated into Mdx muscle fibers are silent despite long-term engraftment. Proc Natl Acad Sci USA. 2005;102(33):11852\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"288_CR43","first-page":"1","volume":"10","author":"A Filareto","year":"2012","unstructured":"Filareto A, Darabi R, Perlingeiro RC. Engraftment of Es-derived myogenic progenitors in a severe mouse model of muscular dystrophy. J Stem Cell Res Ther. 2012;10:1.","journal-title":"J Stem Cell Res Ther"},{"issue":"2","key":"288_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/jcm4020243","volume":"4","author":"I Roca","year":"2015","unstructured":"Roca I, Requena J, Edel MJ, Alvarez-Palomo AB. Myogenic precursors from Ips cells for skeletal muscle cell replacement therapy. J Clin Med. 2015;4(2):243\u201359.","journal-title":"J Clin Med"},{"issue":"5","key":"288_CR45","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1533","volume":"13","author":"T Barberi","year":"2007","unstructured":"Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, Studer L. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med. 2007;13(5):642\u20138.","journal-title":"Nat Med"},{"key":"288_CR46","doi-asserted-by":"publisher","first-page":"1376151","DOI":"10.1155\/2017\/1376151","volume":"2017","author":"Y Kodaka","year":"2017","unstructured":"Kodaka Y, Rabu G, Asakura A. Skeletal muscle cell induction from pluripotent stem cells. Stem Cells Int. 2017;2017:1376151.","journal-title":"Stem Cells Int"},{"issue":"4","key":"288_CR47","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/mus.21317","volume":"40","author":"AL Perez","year":"2009","unstructured":"Perez AL, Bachrach E, Illigens BM, Jun SJ, Bagden E, Steffen L, et al. Cxcr4 enhances engraftment of muscle progenitor cells. Muscle Nerve. 2009;40(4):562\u201372.","journal-title":"Muscle Nerve"},{"issue":"Pt 18","key":"288_CR48","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1242\/jcs.066241","volume":"123","author":"CA Griffin","year":"2010","unstructured":"Griffin CA, Apponi LH, Long KK, Pavlath GK. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci. 2010;123(Pt 18):3052\u201360.","journal-title":"J Cell Sci"},{"issue":"4","key":"288_CR49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/19336918.2016.1227911","volume":"11","author":"K Kowalski","year":"2017","unstructured":"Kowalski K, Kolodziejczyk A, Sikorska M, Placzkiewicz J, Cichosz P, Kowalewska M, et al. Stem cells migration during skeletal muscle regeneration\u2014the role of Sdf-1\/Cxcr4 and Sdf-1\/Cxcr7 axis. Cell Adh Migr. 2017;11(4):384\u201398.","journal-title":"Cell Adh Migr"},{"issue":"1","key":"288_CR50","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1038\/s41598-017-02928-1","volume":"7","author":"Y Maeda","year":"2017","unstructured":"Maeda Y, Yonemochi Y, Nakajyo Y, Hidaka H, Ikeda T, Ando Y. Cxcl12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration. Sci Rep. 2017;7(1):3305.","journal-title":"Sci Rep"},{"key":"288_CR51","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/ncomms2550","volume":"4","author":"A Filareto","year":"2013","unstructured":"Filareto A, Parker S, Darabi R, Borges L, Iacovino M, Schaaf T, et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun. 2013;4:1549.","journal-title":"Nat Commun"},{"issue":"10","key":"288_CR52","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1073\/pnas.0400373101","volume":"101","author":"E Bachrach","year":"2004","unstructured":"Bachrach E, Li S, Perez AL, Schienda J, Liadaki K, Volinski J, et al. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci USA. 2004;101(10):3581\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"267","key":"288_CR53","doi-asserted-by":"publisher","first-page":"176r","DOI":"10.1126\/scitranslmed.3008411","volume":"6","author":"S Biressi","year":"2014","unstructured":"Biressi S, Miyabara EH, Gopinath SD, Carlig PM, Rando TA. A Wnt-Tgfbeta2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Sci Transl Med. 2014;6(267):176r\u2013267r.","journal-title":"Sci Transl Med"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-020-00288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-020-00288-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-020-00288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T23:19:34Z","timestamp":1621379974000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-020-00288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/s40659-020-00288-1","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies were approved by the Ethics Committee at the First Affiliated Hospital of Sun Yat-sen University and in accordance with the Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}